Youth with severe mental illness and complex non-somatic motor abnormalities: conflicting conceptualizations and unequal treatment

被引:3
作者
Peter Andersson
Lee E. Wachtel
Johan Lundberg
Esmail Jamshidi
Johan Bring
Mathias Rask-Andersen
Håkan Jarbin
Jussi Jokinen
Adrian E. Desai Boström
机构
[1] Department of Clinical Neuroscience/Psychology, Karolinska Institute, Stockholm
[2] Centre for Clinical Research Dalarna, Uppsala University, Falun
[3] Kennedy Krieger Institute, Johns Hopkins School of Medicine, Baltimore, MD
[4] Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Karolinska University Hospital, Stockholm
[5] Stockholm Health Care Services, Region Stockholm, Stockholm
[6] Department of Clinical Sciences/Psychiatry, Umeå University, Umeå
[7] Statisticon AB, Uppsala
[8] Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala
[9] Department of Clinical Sciences Lund, Section of Child and Adolescent Psychiatry, Lund University, Lund
[10] Child and Adolescent Psychiatry, Region Halland, Halmstad
[11] Department of Women’s and Children’s Health/Neuropediatrics, Karolinska Institutet, Stockholm
来源
npj Mental Health Research | / 1卷 / 1期
关键词
D O I
10.1038/s44184-022-00013-8
中图分类号
学科分类号
摘要
Two emerging diagnostic concepts promote distinct treatments for youth with acute-onset motor abnormalities and severe concurrent psychiatric symptoms: Pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric catatonia. Both have institutional approval in parts of Europe and in the USA, meriting an unconditional comparison of supporting evidence. Here we report results of qualitative and quantitative analyses of literature and Swedish National Registry Data suggesting that (1) catatonic patients are liable to fulfilling diagnostic criteria for PANS, (2) three conservatively assessed PANS case-reports present with possible unrecognized catatonia, (3) lithium and electroconvulsive therapy usage frequencies in Swedish minors (exclusively recommended for severe mental illness) are strongly intercorrelated and unequally distributed across Swedish counties, (4) established severe mental disorders are rarely overtly considered amongst PANS-specific research and (5) best-available evidence treatments appear markedly superior for pediatric catatonia compared to PANS in both childhood and adolescence. Prioritizing treatments for pediatric catatonia in concerned subjects could markedly improve treatment outcomes. © The Author(s) 2022.
引用
收藏
相关论文
共 58 条
[1]  
Johnson M., Et al., Paediatric acute-onset neuropsychiatric syndrome in children and adolescents: an observational cohort study, Lancet Child Adolesc. Health, 3, pp. 175-180, (2019)
[2]  
Gromark C., Et al., Establishing a pediatric acute-onset neuropsychiatric syndrome clinic: baseline clinical features of the pediatric acute-onset neuropsychiatric syndrome Cohort at Karolinska Institutet, J. Child Adolesc. Psychopharmacol, 29, (2019)
[3]  
Frankovich J., Et al., Multidisciplinary Clinic dedicated to treating youth with pediatric acute-onset neuropsychiatric syndrome: presenting characteristics of the first 47 consecutive patients, J. Child Adolesc. Psychopharmacol, 25, (2015)
[4]  
Swedo S.E., Leckman J.F., Rose N.R., From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome), Pediatr. Ther, 2, (2012)
[5]  
Pfeiffer H.C.V., Et al., Clinical guidance for diagnosis and management of suspected pediatric acute-onset neuropsychiatric syndrome in the Nordic countries, Acta Paediatr, pp. 1-8, (2021)
[6]  
Gromark C., Et al., A two-to-five year follow-up of a pediatric acute-onset neuropsychiatric syndrome Cohort, Child Psychiatry Hum. Dev, 53, pp. 354-364, (2022)
[7]  
Johnson M., Et al., Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): a systematic review, PLoS One, 16, (2021)
[8]  
Bigi S., Licht C., Twilt M., Benseler S.M., OP70–2417: plasma exchange (PLEX) in pediatric neurologic diseases: assessment of safety and efficacy, Eur. J. Paediatr. Neurol, 19, (2015)
[9]  
Guo Y., Tian X., Wang X., Xiao Z., Adverse effects of immunoglobulin therapy, Front. Immunol, 9, (2018)
[10]  
Sorg E.M., Chaney-Catchpole M., Hazen E.P., Pediatric catatonia: a case series-based review of presentation, evaluation, and management, Psychosomatics, 59, pp. 531-538, (2018)